Doppler Evaluation in RA Patients After Adalimumab.

Summary

The purpose is to study the relationship between RA disease activity based on Doppler quantification and the subsequent clinical response (EULAR response) to treatment with Adalimumab during 12 months. The purpose is also to compare the Doppler quantification with conventional clinical methods and semiquantitative Doppler assessment.

Timeline

Start

2012-10

Primary completion

2017-09

Completion

2017-09

Drugs

Indications